re: Weekly Stock Market Plays/Thoughts - March/April

Personally, I think these biotech trials will start being a lot shorter. I know part of his overhaul is to loosen restrictions on the FDA, but I believe the business part of him will say does the medicine work or not. If not, sending it to the chopping block. They want to get premiums and medicine cost down and what better way than companies having to constantly finance retrials.

Just my two cents